Not applicableStudy completedNCT03334344What this trial is testingUsing Virtual Reality (VR) Models for Preoperative PlanningWho this might be right forKidney CancerRenal Cell Carcinoma Ceevra, Inc. 92
Early research (Phase 1)Ended earlyNCT04272034What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more Incyte Corporation 105
Not applicableActive Not RecruitingNCT05703269What this trial is testingComparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving ImmunotherapyWho this might be right forNSCLCRenal Cell CarcinomaBreast Carcinoma+5 more Wake Forest University Health Sciences 58
Early research (Phase 1)Study completedNCT03849469What this trial is testingXmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsWho this might be right forMelanomaCervical CarcinomaPancreatic Carcinoma+20 more Xencor, Inc. 78
Testing effectiveness (Phase 2)Looking for participantsNCT06699602What this trial is testingCemiplimab and Fianlimab in People With Clear Cell Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT04198766What this trial is testingStudy of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)Who this might be right forSolid TumorNon-Small Cell Lung CancerHead and Neck Cancer+5 more Inhibrx Biosciences, Inc 340
Not applicableUnknownNCT01838720What this trial is testingZero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a StageWho this might be right forRenal Cell CarcinomaZero Ischemia RenJi Hospital 90
Testing effectiveness (Phase 2)Study completedNCT00357760What this trial is testingZiv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney CancerWho this might be right forMetastatic Renal Cell Carcinoma National Cancer Institute (NCI) 94
Testing effectiveness (Phase 2)Study completedNCT01164228What this trial is testingSunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By SurgeryWho this might be right forKidney Cancer ECOG-ACRIN Cancer Research Group 87
Testing effectiveness (Phase 2)Looking for participantsNCT05048212What this trial is testingA Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain MetastasesWho this might be right forBrain MetastasesRenal Cell Carcinoma M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT03075423What this trial is testingRandomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCCWho this might be right forMetastatic Renal Cell Carcinoma Goethe University 316
Testing effectiveness (Phase 2)Ended earlyNCT00323791What this trial is testingGemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney CancerWho this might be right forKidney Cancer University of Medicine and Dentistry of New Jersey 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT01684397What this trial is testingPazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer Roswell Park Cancer Institute 51
Testing effectiveness (Phase 2)Ended earlyNCT01545817What this trial is testingEverolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Novartis Pharmaceuticals 74
Not applicableStudy completedNCT06778538What this trial is testingEvaluation of HPGD and SCLO2A1 Expression in Clear Cell Renal Cell Carcinoma PatientsWho this might be right forClear Cell Renal Cell Carcinoma (ccRCC) Shang Panfeng 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06500455What this trial is testingTesting Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the BrainWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Digestive System Carcinoma+7 more NRG Oncology 274
Testing effectiveness (Phase 2)UnknownNCT00002589What this trial is testingLymphocyte Therapy in Treating Patients With Kidney CancerWho this might be right forKidney Cancer National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Study completedNCT00113217What this trial is testingNeoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell CarcinomaWho this might be right forRenal Cell CarcinomaKidney Cancer M.D. Anderson Cancer Center 52
Not applicableEnded earlyNCT02138578What this trial is testingTrial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma University of Michigan Rogel Cancer Center 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07277972What this trial is testingIparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic TherapyWho this might be right forRCC, Renal Cell Cancer Tianjin Medical University Cancer Institute and Hospital 36